This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignees: Centre Leon Berard, Centre National De La Recherche Scientifique, Hospices Civils De Lyon. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 39 
1 out of 5,383 
1 out of 46 
Years Active: 2020
Title: Hichem Claude Mertani: Innovator in Cancer Treatment
Introduction
Hichem Claude Mertani is a notable inventor based in Lyons, France. He has made significant contributions to the field of cancer treatment through his innovative research and development of therapeutic antibodies.
Latest Patents
Mertani holds a patent for "Anti-CK8 antibodies for use in the treatment of colorectal cancers." This patent involves a human CK8 antigen peptide and an antibody that specifically binds to the peptide with the amino acid sequence of SEQ ID No. 29. These molecules are designed for the detection and treatment of tumors that express the CK8 protein on their surface.
Career Highlights
Throughout his career, Mertani has worked with prominent organizations such as International Drug Development Biotech and Université Claude Bernard – Lyon 1. His work has focused on advancing the understanding and treatment of colorectal cancers.
Collaborations
Mertani has collaborated with esteemed colleagues, including Marie Alexandra Albaret and Jean-Jacques Diaz. Their joint efforts have contributed to the advancement of cancer research and therapeutic strategies.
Conclusion
Hichem Claude Mertani's innovative work in developing anti-CK8 antibodies represents a significant advancement in cancer treatment. His contributions continue to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile